Change in the thyroid function by use of deferoxamine in a patient with hemochromatosis complicated by hyperthyroidism.
We report on a 74-year-old female patient with primary hemochromatosis complicated by hyperthyroidism. The serum ferritin level was reduced throughout a 217 day administration of deferoxamine (1 g/day). At the same time, the thyroid gland was changed from hyper- to hypo- functional proportionally.
Kubota
K
K
Department of Medicine, Kusatsu Branch Hospital, Gunma University School of Medicine, Japan.
Kurabayashi
H
H
Tamura
J
J
Kawada
E
E
Tamura
K
K
Nagashima
K
K
Shirakura
T
T
D000368:Aged; D003676:Deferoxamine / Q000627:therapeutic use; D005260:Female; D006432:Hemochromatosis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D011441:Propylthiouracil / Q000627:therapeutic use; D013960:Thyroid Function Tests
D011441:Propylthiouracil; D003676:Deferoxamine